
Publications of Claney Lebev Pereira
All genres
Journal Article (29)
1.
Journal Article
A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae. Vaccine (2022)
2.
Journal Article
21 (1-2), pp. 241 - 247 (2020)
Thermodynamic and structural behaviour of α-Galactosylceramide and C6-functionalized α-GalCer in 2D layers at the air-liquid interface. ChemBioChem: A European Journal of Chemical Biology 3.
Journal Article
16, pp. 1693 - 1699 (2020)
Synthesis of Streptococcus pneumoniae serotype 9V oligosaccharide antigens. Beilstein Journal of Organic Chemistry 4.
Journal Article
15 (9), pp. 2395 - 2405 (2020)
Sequential linkage of carbohydrate antigens to mimic capsular polysaccharides: towards semisynthetic glycoconjugate vaccine candidates against Streptococcus pneumoniae serotype 14. ACS Chemical Biology 5.
Journal Article
116 (6), pp. 1958 - 1967 (2019)
Microbe-focused glycan array screening platform. Proceedings of the National Academy of Sciences of the United States of America 6.
Journal Article
9 (5), pp. 1279 - 1288 (2018)
A modular synthetic route to size-defined immunogenic Haemophilus influenzae b antigens is key to the identification of an octasaccharide lead vaccine candidate. Chemical Science 7.
Journal Article
61 (11), pp. 4918 - 4927 (2018)
Synthesis, liposomal formulation, and immunological evaluation of a minimalistic carbohydrate-α-GalCer vaccine candidate. Journal of Medicinal Chemistry 8.
Journal Article
563 (7733), pp. 705 - 709 (2018)
Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity. Nature 9.
Journal Article
115 (52), pp. 13353 - 13358 (2018)
Improving vaccines against Streptococcus pneumoniae using synthetic glycans. Proceedings of the National Academy of Sciences of the United States of America 10.
Journal Article
24 (16), pp. 4181 - 4187 (2018)
Identification of the minimal glycotope of Streptococcus pneumoniae 7F capsular polysaccharide using synthetic oligosaccharides. Chemistry – A European Journal 11.
Journal Article
140 (8), pp. 3120 - 3127 (2018)
Total synthesis of a densely functionalized Plesiomonas shigelloides serotype 51 aminoglycoside trisaccharide antigen. Journal of the American Chemical Society 12.
Journal Article
4 (3), pp. 357 - 361 (2018)
Development of an efficacious, semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 1. ACS Central Science 13.
Journal Article
24 (12), pp. 2868 - 2872 (2018)
Synergistic glycosylation as key to the chemical synthesis of an outer core octasaccharide of Helicobacter pylori. Chemistry – A European Journal 14.
Journal Article
139 (41), pp. 14783 - 14791 (2017)
A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease. Journal of the American Chemical Society 15.
Journal Article
114 (42), pp. 11063 - 11068 (2017)
Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5. Proceedings of the National Academy of Sciences of the United States of America 16.
Journal Article
9 (380), eaaf5347 (2017)
A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine. Science Translational Medicine 17.
Journal Article
56 (45), pp. 13973 - 13978 (2017)
A semi-synthetic glycoconjugate vaccine candidate for carbapenem-resistant Klebsiella pneumoniae. Angewandte Chemie International Edition 18.
Journal Article
13, pp. 1994 - 1998 (2017)
1,3-Dibromo-5,5-dimethylhydantoin as promoter for glycosylations using thioglycosides. Beilstein Journal of Organic Chemistry 19.
Journal Article
23 (8), pp. 1014 - 1022 (2016)
Synthetic lipoteichoic acid glycans are potential vaccine candidates to protect from Clostridium difficile infections. Cell Chemical Biology 20.
Journal Article
11 (2), pp. 335 - 344 (2016)
Deciphering antigenic determinants of Streptococcus pneumoniae serotype 4 capsular polysaccharide using synthetic oligosaccharides. ACS Chemical Biology